
|Videos|March 12, 2017
Incorporating Biologic Factors Into Breast Cancer Staging
Author(s)Kelly K. Hunt, MD
Kelly K. Hunt, MD, professor of Surgery, and chair, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, discusses incorporating biologic factors into breast cancer staging.
Advertisement
Kelly K. Hunt, MD, professor of Surgery, and chair, Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, discusses incorporating biologic factors into breast cancer staging.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Sacituzumab Govitecan Misses PFS in First-Line HR+/HER2– Metastatic Breast Cancer
2
Exploring the IO Interface: Bridging Knowledge Gaps in Immunotoxicity Management
3
Medication Burden Linked With Acute Care Use in ARSI-Treated Prostate Cancer
4
First-in-Human Data Support Izalontamab in Advanced Epithelial Tumors
5








































